What's the Outlook for Novavax Stock?

Shares of Novavax (NASDAQ: NVAX) have retreated from their recent peaks, but this biotech stock is still up over 2,610% in 2020, and investors want to know if it can jump higher once again. 

On one hand, investors are right to be worried about the future of any 33-year-old vaccine developer that hasn't produced any successful vaccines yet. That said, governments around the world are supporting the development of Novavax's experimental coronavirus vaccine. 

Image source: Getty Images.

Continue reading

Source Fool.com